U.S. Hospitality Stock News

In recent months, JBS has faced legal action from Greenpeace in the Netherlands over alleged environmental and human rights failings, while China suspended beef imports from its Vilhena, Brazil plant after detecting a growth hormone. Together, these disputes highlight how regulatory and ethical scrutiny in key export markets can directly challenge JBS’s global expansion plans and operating flexibility. We’ll now examine how the China import suspension, in particular, may reshape JBS’s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Last week's profit announcement from Walmart Inc. ( NASDAQ:WMT ) was underwhelming for investors, despite headline...

Investors were disappointed with Park Aerospace Corp.'s ( NYSE:PKE ) earnings, despite the strong profit numbers. Our...

The market was pleased with the recent earnings report from Bath & Body Works, Inc. ( NYSE:BBWI ), despite the profit...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The recent 19% drop in aTyr Pharma, Inc.'s ( NASDAQ:ATYR ) stock could come as a blow to insiders who purchased...

Readers hoping to buy AMERISAFE, Inc. ( NASDAQ:AMSF ) for its dividend will need to make their move shortly, as the...

In late May 2026, Baker Hughes announced multi-year contract extensions with Equinor in the North Sea and Petrobras in Brazil, expanding its integrated drilling, well services, and intervention work across major offshore basins using advanced technologies like Kantori, TRU-ARMS, and the PRIME Technology Platform. These wins, alongside rising U.S. rig counts reported by Baker Hughes, highlight the company’s central role in both traditional offshore development and broader upstream activity,...

Shelf registration puts FB Financial’s ESOP plans in focus FB Financial (FBK) has filed a shelf registration for up to $105.3 million in common shares tied to an employee stock ownership plan, bringing potential dilution and capital flexibility to investors’ attention. See our latest analysis for FB Financial. The ESOP related shelf registration comes after a mixed stretch for the stock, with the share price currently at US$52.92, a year to date share price return of 5.7% in decline, a 1 year...

Recent trading context for Brady stock Brady (BRC) shares have been under pressure recently, with the stock down 0.2% on the day, 13.5% over the past week, and 3.9% over the past month as investors reassess valuation. See our latest analysis for Brady. The recent 1-day share price return decline of 15.06% sits against a softer 30-day share price return fall of 3.89%, while the 3-year total shareholder return of 61.65% shows that long term holders have still been rewarded. If this kind of...

Autohome Inc. recently reported first‑quarter 2026 results showing weaker sales, revenue, and net income year over year, while also approving a US$0.66 per ADS cash dividend and completing a US$62.3 million buyback of 3,465,236 shares, representing 2.99% of its share base. At the same time, Autohome filed a US$539.76 million shelf registration for 31,200,000 common shares related to its ESOP and proposed replacing its Seventh Amended and Restated Memorandum and Articles of Association with...

Weatherford International (WFRD) is back in focus after recent analyst commentary lifted fair value estimates, pointing to a more favorable view on the company’s revenue growth potential, profit margins, and overall earnings profile. See our latest analysis for Weatherford International. The recent analyst update comes after a powerful run in Weatherford International’s stock, with a year to date share price return of 27.33% and a 1 year total shareholder return of 111.80% that points to...

RenaissanceRe Holdings recently highlighted that disciplined underwriting, stronger investment income, and ongoing portfolio optimization have reinforced its capital position and underwriting performance. An interesting aspect is how the company is pairing these efficiency gains with continued capital returns to shareholders, aiming to sustain earnings stability despite premium growth and leverage pressures. Next, we’ll examine how this focus on disciplined underwriting and portfolio...

In the first quarter of 2026, Exelon reported revenue and adjusted net income that exceeded expectations and increased year over year, while reaffirming its full-year 2026 earnings outlook. The company also lifted its 2026–2029 capital plan to US$41.70 billion, underscoring a larger grid and infrastructure program that now depends more heavily on regulatory approval and financing conditions. Next, we’ll examine how Exelon’s expanded US$41.70 billion infrastructure plan may reshape its...

The Morning Bull - US Market Morning Update Tuesday, Jun, 9 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.2% and Nasdaq-100 minis ahead roughly 0.6%, as investors weigh strong US jobs data against rising borrowing costs. Payrolls in May added 172,000 jobs versus 85,000 expected and the unemployment rate held at 4.3%, a combination that keeps talk of a possible year end interest rate hike alive. At the same time, the 10 year Treasury...

American Battery Technology Company recently won its appeal with the U.S. Department of Energy, securing full reinstatement of a US$115 million grant to fund the first phase of its Tonopah Flats Lithium Project refinery, with all technical and commercial milestones preserved and the schedule adjusted for the review-related delay. This decision follows multi-administration federal backing and a Pre-Feasibility Study outlining a long-life lithium project, highlighting sustained government...

In early June 2026, Xeris Biopharma director Marla Persky sold 15,500 shares under a Rule 10b5-1 plan, then received new restricted stock units and stock options as part of the company’s 2018 Stock Option and Incentive Plan. Around the same time, Xeris Biopharma reported a 38% year-on-year increase in Q1 2026 revenue and earnings per share above market expectations, underscoring stronger-than-anticipated operating momentum. Now we’ll examine how Xeris’s better-than-expected Q1 revenue...

Why Permian Resources Stock Is Back in Focus Permian Resources (PR) moved back onto investor radar after reporting first quarter 2026 adjusted earnings of $0.39 per share, which topped estimates. The results were supported by stronger production, efficiency gains, and a dividend-centered capital plan that was reaffirmed. See our latest analysis for Permian Resources. Those results arrive while the stock trades at $19.59, with a 36.04% year to date share price return and a 48.06% one year...

In late May 2026, BBB Foods Inc. completed a US$432.39 million follow-on equity offering of 13,304,174 Class A common shares at US$32.50 per share, following a shelf registration filed for the same security. This capital raise, executed at a modest discount, reinforces BBB Foods’ capacity to fund its hard discount expansion in Mexico while broadening its public float. With the follow-on offering now complete, we’ll examine how this fresh equity capital shapes BBB Foods’ expansion-focused...

Optical Cable (OCC) is back on investors radar after its latest Q2 earnings reported sales of US$22.21 million and net income of US$1.06 million, compared with a net loss in the same period a year earlier. See our latest analysis for Optical Cable. The sharp 54.47% 1 day share price return after the Q2 release, alongside a 315.75% year to date share price return and very large 1 year total shareholder return, suggests momentum has accelerated as the turnaround in profitability sinks in. If...

Ducommun (NYSE:DCO) disclosed a restatement of its 2024 and 2025 financial statements related to stock based compensation expense recognition. A law firm has launched an investigation into potential securities law violations connected to this restatement. The review focuses on whether the company’s accounting and disclosures around equity compensation met regulatory requirements. Ducommun, a long standing supplier to the aerospace, defense, and industrial sectors, now sits under a spotlight...

In recent weeks, Devon Energy advanced its merger with Coterra Energy, moved toward divesting its Marcellus asset after receiving an approximately US$8.00 billion offer, and filed to issue up to 175,000 shares tied to preferred stock conversion. Alongside these changes, Devon announced a new share repurchase authorization exceeding US$5.00 billion and a higher fixed dividend, highlighting a sharper focus on returning cash to shareholders. We’ll now examine how the planned Marcellus...

Ultragenyx Pharmaceutical (RARE) is back in focus after the FDA accepted its resubmitted BLA for UX111, assigning a September 19, 2026 PDUFA date, alongside growing institutional interest in the GTX-102 program. See our latest analysis for Ultragenyx Pharmaceutical. Even with the fresh regulatory progress on UX111 and growing attention on GTX-102, the stock’s momentum has been weak, with the share price down 17.34% over the past 30 days and the 1-year total shareholder return declining...